Skip to main content

New: A clinical tool on PPIs

The Centre for Effective Practice has released its first clinical tool of 2020: Managing Proton Pump Inhibitor Use in Older Adults.

When the ongoing reason for using proton pump inhibitors is unclear, there may be more risks than benefits to the patient. Some risks include: clostridium difficile infection, bone loss and fractures, diarrhea, impaired B12 absorption, hypomagnesemia, and pneumonia.

This tool can help guide discussions and assessments with patients aged 65+ on the potential harms and benefits of PPIs. It contains information about how to safely discontinue, start or continue prescribing, and alternatives to PPIs for older adults.

Subscribe to our newsletter below to get the CEP's latest clinical tool right in your inbox!

This site uses cookies to improve visitor experience and functioning. By scrolling this page, clicking a link or continuing to browse, you agree to the use of cookies. Please consult your browser settings (and browser plugins) to configure whether and how you receive cookies.